Cargando…
Future prospects of Qiliqiangxin on heart failure: epigenetic regulation of regeneration
Autores principales: | Tao, Lichan, Shen, Shutong, Li, Xinli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3807038/ https://www.ncbi.nlm.nih.gov/pubmed/24167520 http://dx.doi.org/10.3389/fgene.2013.00221 |
Ejemplares similares
-
Common Variants for Heart Failure
por: Shen, Shutong, et al.
Publicado: (2015) -
Traditional Chinese Medication Qiliqiangxin attenuates cardiac remodeling after acute myocardial infarction in mice
por: Tao, Lichan, et al.
Publicado: (2015) -
Study protocol: Traditional Chinese Medicine (TCM) syndrome differentiation for heart failure patients and its implication for long-term therapeutic outcomes of the Qiliqiangxin capsules
por: Leung, Alice Yeuk Lan, et al.
Publicado: (2021) -
Qiliqiangxin Capsules Optimize Cardiac Metabolism Flexibility in Rats With Heart Failure After Myocardial Infarction
por: Cheng, Wenkun, et al.
Publicado: (2020) -
Study protocol for a randomized controlled trial: Qiliqiangxin in heart failUre: assESsment of reduction in morTality (QUEST)
por: Yao, Wenming, et al.
Publicado: (2020)